<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The 10th International Congress on <z:hpo ids='HP_0003613'>Antiphospholipid Antibodies</z:hpo> (Sicily, Italy, September 29-October 3, 2002) (Fig. 1) provided enlightening aspects on the recent developments in <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) and <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> in more than 150 lectures and posters </plain></SENT>
<SENT sid="1" pm="."><plain>Researchers from <z:hpo ids='HP_0000001'>all</z:hpo> aspects of medicine attended the meeting, implicating the systemic characteristics of APS </plain></SENT>
<SENT sid="2" pm="."><plain>The important breakthroughs are summarized </plain></SENT>
</text></document>